Abstract:Human microbiome contains billions of microorganisms that play important roles in the biological system and different diseases. Due to its complexity, conventional culture-independent technology may underestimate the value of low-abundance bacteria, which calls for a highly efficient method for its enrichment and comprehensive analysis. In this study, we developed a recycling free-flow isoelectric focusing (RFFIEF) method-based electrophoresis method to separate salivary microbiome. First, we used Escherichia coli (DH5α) as a model for RFFIEF method development, which was focused in a narrow pH range (0.38 pH unit). The recovery rate was 80.81% with 5.85% relative standard deviation (n = 5). The optimized method was then adopted to separate the human salivary microbiome into 32 fractions, followed by 16S rRNA gene sequencing and metaproteomics analysis. After RFFIEF fractionation, we identified 508 bacterial genera, which increased by 225% on average (n = 3) when compared to the results before fractionation. We further compared the compositional change of microbiome in the saliva of lung cancer group (n = 22) and control group (n = 21) through RFFIEF. Quantitative results demonstrated that six bacterial genera were upregulated dramatically in the lung cancer group, while two genera were downregulated. Through qPCR verification in an independent sample set (n = 48), we confirmed that genus Granulicatella was significantly upregulated in the lung cancer group, whereas Pseudomonas was remarkably downregulated (p < 0.001). RFFIEF is an efficient and reproducible technology to fractionate the microbiome for its comprehensive analysis, which can be further applied to the in-depth study of the complex microbiomes and contribute to the discovery of disease-associated bacteria.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c02627?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c02627</a>.Detailed supporting materials and methods, workflow for the pretreatment of saliva microbiome, the recovery rate, morphology of E. coli before and after RFFIEF separation, number of identified salivary bacteria, Shannon rarefaction curve, SDS-PAGE of salivary microbial proteins, STAMP analysis of significantly different bacteria, pH gradient of RFFIEF fractions for salivary microbiome, Venn diagram of identified salivary microbiome, distribution bar plot, Venn diagram of bacterial genera from control and cancer groups, validation of Rothia, Venn diagram of identified salivary microbiome by sequencing and metaproteomics approach, demographic information on enrolled lung cancer patients and healthy subjects, salivary bacteria significantly enriched via RFFIEF, significantly different salivary bacteria between the lung cancer group and healthy group, 16S rRNA primers for qPCR, the identified microbial proteins, and list of species and their species-specific peptides that were uniquely identified in each fraction (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c02627/suppl_file/ac0c02627_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Free-Flow Isoelectric Focusing for Comprehensive Separation and Analysis of Human Salivary Microbiome for Lung Cancer

In-Depth Metaproteomics Analysis of Oral Microbiome for Lung Cancer

Pyrosequencing Analysis of the Salivary Microbiota of Healthy Chinese Children and Adults

Characterization of Lung and Oral Microbiomes in Lung Cancer Patients Using Culturomics and 16S rRNA Gene Sequencing

Proteomic Analysis of Human Saliva from Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry

Predictive value of the presence of Prevotella and the ratio of Porphyromonas gingivalis to Prevotella in saliva for esophageal squamous cell carcinoma

Affinity Chromatography Assisted Comprehensive Phosphoproteomics Analysis of Human Saliva for Lung Cancer.

Microbiota Core in Central Lung Cancer with Streptococcal Enrichment as a Possible Diagnostic Marker

Integrated N-glycoproteomics Analysis of Human Saliva for Lung Cancer.

Identification of microbial markers associated with lung cancer based on multi‐cohort 16 s rRNA analyses: A systematic review and meta‐analysis

Prediction of lung cancer using novel biomarkers based on microbiome profiling of bronchoalveolar lavage fluid

Proteomic and N-glycoproteomic quantification reveal aberrant changes in the human saliva of oral ulcer patients.

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

Diagnostic Value of the Microbiome in the Bronchoalveolar Fluid of Patients with Lung masses and its Relationship with their Clinical Features

Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.

Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma

[Analysis of Salivary Microbiota Characteristics in Patients With Pulmonary Nodules: A Prospective Nonrandomized Concurrent Controlled Trial]

Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?

Salivary Microbial Dysbiosis is Associated with Systemic Inflammatory Markers and Predicted Oral Metabolites in Non-Small Cell Lung Cancer Patients

Facile preparation of salivary extracellular vesicles for cancer proteomics

An integrated metaproteomics workflow for studying host-microbe dynamics in bronchoalveolar lavage samples applied to cystic fibrosis disease